Bupivacaine liposomal injection was recently approved by the US Food and Drug Administration (FDA) as a local anesthetic for use in management of postsurgical pain in adults. When compared to placebo, bupivacaine liposomal decreases postoperative pain and opioid use. This review examines the efficacy of bupivacaine liposomal when compared to conventional bupivacaine ± epinephrine using published and unpublished data provided to the FDA by the manufacturer.
CandiottiK.Liposomal bupivacaine: An innovative nonopioid local analgesic for the management of postsurgical pain. Pharmacotherapy. 2012;32:19S–26S.
3.
ChaharP, CummingsKC. Liposomal bupivacaine: A review of a new bupivacaine formulation. J Pain Res. 2012;5:257–264
4.
New opportunities for hospitals to improve economic efficiency and patient outcomes: The case of Exparel, a long-acting non-opioid local analgesic. A Frost & Sullivan White Paper. 2012. http://www.frost.com/prod/servlet/cpo/252218999. Accessed April 2, 2014.
BergeseSD, RamamoorthyS, PatouG, Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107–116.
7.
GorfineSR, OnelE, PatouG, KrivokapicZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: A multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54:1552–1559.
8.
GolfM, DanielsSE, OnelE.A phase 3, randomized, placebo-controlled trial of DepoFoam bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28:776–788.
9.
DastaJ, RamamoorthyS, PatouG, SinatraR.Bupivacaine liposomal injectable suspension compared with bupivacaine HCL for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28:1609–1615.
10.
Marcaine [package insert]. Lake Forest, IL: Hospira, Inc; October 2011.
11.
YoungerJ, McCueR, MackeyS.Pain outcomes: A brief review of instruments and techniques. Curr Pain Headache Rep. 2009;13(1):39–43.
12.
Exparel [package insert]. San Diego, CA: Pacira Pharmaceuticals, Inc; June 2012.
13.
BaxterR, BramlettK, OnelE, DanielsS.Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: A review of data from ten prospective, controlled clinical studies. Clin Ther. 2013;35:312–320.
14.
RichardBM, RickertDE, DoolittleD, Pharmacokinetic compatibility study of lidocaine with EXPAREL in Yucatan miniature pigs. ISRN Pharm. 2011;2011:582351. doi:10.5402/2011/582351.
15.
Diaz-PalaciosGA, Eslava-SchmalbachJH. Perirectal block for out-patient anorectal surgery: A new technique. Biomedica. 2011;31:196–199.
16.
Potential for wrong route errors with Exparel (bupivacaine liposome injectable suspension). National Alert Network. March 2012. http://www.ismp.org/NAN/files/NAN-20120318.pdf. Accessed April 3, 2014.
